Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -8.64 | 27.14 |
| PEG Ratio (TTM) | -0.38 | 4.04 |
| P/S Ratio (TTM) | 0.38 | 2.03 |
| P/B Ratio (TTM) | 0.91 | 2.66 |
| P/FCF Ratio (TTM) | 28.94 | 15.82 |
| Price to 5YR AVG Earnings Ratio | N/A | 12.58 |
| Price to 5YR AVG FCF Ratio | N/A | 23.96 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.01% | 5.51% |
| ROE (TTM) | -10.11% | 11.81% |
| Net Profit Margin (TTM) | -4.43% | 6.74% |
| ROIC 5YR AVG | N/A | 10.24% |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.15% | -196.96% | N/A |
| Revenue | 1.06% | 24.69% | N/A |
| Net Income | 3.71% | -193.51% | N/A |
| Cash Flow | 165.43% | 875.40% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.95 | 1.35 |
| Quick Ratio (TTM) | 1.36 | 0.78 |
| D/E Ratio (TTM) | 1.87 | 0.95 |
| Interest Coverage (TTM) | 0.51 | 10.28 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 0.83 | 3.16 |
| LTL to 5YR AVG FCF | N/A | 6.50 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.39% |